Nanhua Bio Medicine Co Ltd Asset Resilience Ratio

Latest as of March 2026: 11.81%

Nanhua Bio Medicine Co Ltd asset resilience ratio. Nanhua Bio Medicine Co Ltd (000504) has an Asset Resilience Ratio of 11.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000504 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥120.00 Million

≈ $17.56 Million USD Cash + Short-term Investments

Total Assets

CN¥1.02 Billion

≈ $148.73 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of Nanhua Bio Medicine Co Ltd (1993–2024)

Asset resilience ratio of Nanhua Bio Medicine Co Ltd from 1993 to 2024. This chart shows how Nanhua Bio Medicine Co Ltd's Asset Resilience Ratio has changed over time. Read Nanhua Bio Medicine Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Nanhua Bio Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Nanhua Bio Medicine Co Ltd's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥120.00 Million	11.81%
Total Liquid Assets	CN¥120.00 Million	11.81%

Asset Resilience Insights

Moderate Liquidity: Nanhua Bio Medicine Co Ltd has 11.81% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Nanhua Bio Medicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Nanhua Bio Medicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Nanhua Bio Medicine Co Ltd Asset Resilience Ratio by Year (1993–2024)

Nanhua Bio Medicine Co Ltd asset resilience ratio by year from 1993 to 2024. The table below shows the annual Asset Resilience Ratio data for Nanhua Bio Medicine Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.10%	CN¥607.89K ≈ $88.95K	CN¥608.17 Million ≈ $88.99 Million	-0.12pp
2023-12-31	0.22%	CN¥1.72 Million ≈ $251.45K	CN¥771.38 Million ≈ $112.88 Million	-0.08pp
2022-12-31	0.30%	CN¥1.69 Million ≈ $246.59K	CN¥553.06 Million ≈ $80.93 Million	+0.23pp
2021-12-31	0.08%	CN¥501.82K ≈ $73.43K	CN¥659.25 Million ≈ $96.47 Million	-0.04pp
2020-12-31	0.12%	CN¥657.31K ≈ $96.19K	CN¥556.14 Million ≈ $81.38 Million	-0.24pp
2019-12-31	0.36%	CN¥961.86K ≈ $140.75K	CN¥268.33 Million ≈ $39.27 Million	+0.04pp
2018-12-31	0.32%	CN¥1.09 Million ≈ $158.85K	CN¥342.71 Million ≈ $50.15 Million	-0.03pp
2017-12-31	0.35%	CN¥1.41 Million ≈ $206.03K	CN¥404.78 Million ≈ $59.23 Million	-0.22pp
2016-12-31	0.56%	CN¥1.70 Million ≈ $248.19K	CN¥301.19 Million ≈ $44.07 Million	-2.06pp
2012-12-31	2.62%	CN¥1.99 Million ≈ $291.59K	CN¥76.06 Million ≈ $11.13 Million	+1.78pp
2011-12-31	0.84%	CN¥2.33 Million ≈ $341.54K	CN¥276.47 Million ≈ $40.46 Million	-0.30pp
2010-12-31	1.14%	CN¥3.28 Million ≈ $479.91K	CN¥286.82 Million ≈ $41.97 Million	+0.37pp
2009-12-31	0.77%	CN¥3.18 Million ≈ $465.74K	CN¥412.24 Million ≈ $60.32 Million	+0.50pp
2008-12-31	0.27%	CN¥1.47 Million ≈ $215.32K	CN¥536.52 Million ≈ $78.51 Million	-0.69pp
2007-12-31	0.96%	CN¥6.54 Million ≈ $957.26K	CN¥681.31 Million ≈ $99.70 Million	-1.37pp
2006-12-31	2.33%	CN¥14.86 Million ≈ $2.17 Million	CN¥637.48 Million ≈ $93.28 Million	+0.58pp
2005-12-31	1.75%	CN¥11.34 Million ≈ $1.66 Million	CN¥648.02 Million ≈ $94.83 Million	-0.05pp
2004-12-31	1.80%	CN¥10.87 Million ≈ $1.59 Million	CN¥603.88 Million ≈ $88.37 Million	+1.20pp
2003-12-31	0.60%	CN¥3.56 Million ≈ $521.12K	CN¥595.75 Million ≈ $87.18 Million	+0.13pp
2002-12-31	0.47%	CN¥2.90 Million ≈ $424.82K	CN¥620.07 Million ≈ $90.74 Million	+0.01pp
2001-12-31	0.46%	CN¥2.75 Million ≈ $402.20K	CN¥600.98 Million ≈ $87.94 Million	-0.93pp
2000-12-31	1.39%	CN¥8.30 Million ≈ $1.21 Million	CN¥597.05 Million ≈ $87.37 Million	-0.14pp
1999-12-31	1.53%	CN¥7.32 Million ≈ $1.07 Million	CN¥479.49 Million ≈ $70.16 Million	-0.27pp
1998-12-31	1.80%	CN¥11.33 Million ≈ $1.66 Million	CN¥631.05 Million ≈ $92.34 Million	+0.52pp
1997-12-31	1.27%	CN¥9.46 Million ≈ $1.38 Million	CN¥743.86 Million ≈ $108.85 Million	+0.43pp
1996-12-31	0.84%	CN¥6.46 Million ≈ $944.57K	CN¥766.94 Million ≈ $112.23 Million	-6.37pp
1995-12-31	7.21%	CN¥62.10 Million ≈ $9.09 Million	CN¥861.03 Million ≈ $126.00 Million	-0.17pp
1994-12-31	7.38%	CN¥61.36 Million ≈ $8.98 Million	CN¥831.10 Million ≈ $121.62 Million	-5.30pp
1993-12-31	12.69%	CN¥99.25 Million ≈ $14.52 Million	CN¥782.34 Million ≈ $114.48 Million	--

pp = percentage points

About Nanhua Bio Medicine Co Ltd

SHE:000504 China Biotechnology

Market Cap

$384.41 Million

CN¥2.63 Billion CNY

Market Cap Rank

#13314 Global

#3912 in China

Share Price

CN¥7.96

Change (1 day)

+2.58%

52-Week Range

CN¥7.20 - CN¥13.73

All Time High

CN¥29.98